Kirby McInerney LLP is investigating potential claims against the Board of Directors of Patient Safety Technologies, Inc. (“Patient” or the “Company”) (OTC:PSTX) concerning the proposed acquisition of the Company by Stryker Corporation (“Stryker”) (NYSE:SYK). Under the terms of the definitive merger agreement, Patient stockholders will receive $2.22 in cash for each share of Patient owned, valuing the transaction at approximately $120 million. The investigation concerns whether the Patient Board of Directors violated its fiduciary duties by agreeing to the proposed transaction and whether the $2.22 per share proposed consideration adequately values Patient’s common stock. If you are a Patient stockholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at email@example.com, by telephone at (212) 699-1145 or (888) 529-4787, or by filling out this contact form. There is no cost or obligation to you. Kirby McInerney LLP is a New York-based law firm concentrating in securities, shareholder, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.